Carl Zeiss Meditec AG (AFX) — Capital Reinvestment Ratio
Carl Zeiss Meditec AG (AFX) has a Capital Reinvestment Ratio of 0.36x as of September 2025, meaning it reinvests 0% of its operating cash flow (€209.86 Million) in capital expenditures (€76.59 Million). See Carl Zeiss Meditec AG (AFX) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Carl Zeiss Meditec AG Capital Reinvestment Ratio (2014–2025)
This chart tracks Carl Zeiss Meditec AG's Capital Reinvestment Ratio across 12 annual periods. Check how aggressively does Carl Zeiss Meditec AG reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Carl Zeiss Meditec AG (2014–2025)
Year-by-year Capital Reinvestment Ratio for Carl Zeiss Meditec AG from 2014 to 2025. For live market cap and broader valuation context, see AFX market cap overview.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.36x | €209.86 Million | €76.59 Million | ▼ -40.7% |
| 2024 | 0.62x | €247.32 Million | €152.20 Million | ▲ +135.2% |
| 2023 | 0.26x | €250.86 Million | €65.65 Million | ▲ +15.1% |
| 2022 | 0.23x | €188.20 Million | €42.80 Million | ▲ +173.8% |
| 2021 | 0.08x | €362.66 Million | €30.12 Million | ▼ -49.4% |
| 2020 | 0.16x | €178.53 Million | €29.32 Million | ▲ +77.3% |
| 2019 | 0.09x | €219.63 Million | €20.35 Million | ▲ +4.9% |
| 2018 | 0.09x | €187.21 Million | €16.54 Million | ▼ -75.6% |
| 2017 | 0.36x | €37.73 Million | €13.66 Million | ▲ +44.9% |
| 2016 | 0.25x | €111.77 Million | €27.92 Million | ▲ +45.0% |
| 2015 | 0.17x | €56.74 Million | €9.77 Million | ▼ -2.5% |
| 2014 | 0.18x | €63.10 Million | €11.14 Million | — |